Related references
Note: Only part of the references are listed.Manipulating the NF-κB pathway in macrophages using mannosylated, siRNA-delivering nanoparticles can induce immunostimulatory and tumor cytotoxic functions
Ryan A. Ortega et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
How successful is nuclear targeting by nanocarriers?
Salma N. Tammam et al.
JOURNAL OF CONTROLLED RELEASE (2016)
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Weiping Zou et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Diffuse large B-cell lymphoma of the breast: prognostic factors and treatment outcomes
Yao Sun et al.
ONCOTARGETS AND THERAPY (2016)
Targeting myeloid cells using nanoparticles to improve cancer immunotherapy
Zohreh Amoozgar et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Liposome encapsulated zoledronate favours M1-like behaviour in murine macrophages cultured with soluble factors from breast cancer cells
Sofia Sousa et al.
BMC CANCER (2015)
Tumour-associated macrophages correlate with poor prognosis in myxoid liposarcoma and promote cell motility and invasion via the HB-EGF-EGFR-PI3K/Akt pathways
A. Nabeshima et al.
BRITISH JOURNAL OF CANCER (2015)
Antibody-Dependent Phagocytosis of Tumor Cells by Macrophages: A Potent Effector Mechanism of Monoclonal Antibody Therapy of Cancer
Nuray Guel et al.
CANCER RESEARCH (2015)
Specific hepatic delivery of procollagen 1(I) small interfering RNA in lipid-like nanoparticles resolves liver fibrosis
Carolina Jimenez Calvente et al.
HEPATOLOGY (2015)
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
Douglas Marvel et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Multicomponent mannose-containing liposomes efficiently deliver RNA in murine immature dendritic cells and provide productive anti-tumour response in murine melanoma model
Oleg V. Markov et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Nanoparticulate immunotherapy for cancer
Chintan H. Kapadia et al.
JOURNAL OF CONTROLLED RELEASE (2015)
The interaction of anticancer therapies with tumor-associated macrophages
Alberto Mantovani et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Tumor-Infiltrating Dendritic Cells in Cancer Pathogenesis
Jo Marie Tran Janco et al.
JOURNAL OF IMMUNOLOGY (2015)
Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells
Annie A. Wu et al.
ONCOIMMUNOLOGY (2015)
Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment
Anders Olsson et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Effect of tumor cells and tumor microenvironment on NK-cell function
Massimo Vitale et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Increased frequencies of CD11b+CD33+CD14+HLA-DRlow myeloid-derived suppressor cells are an early event in melanoma patients
Berenice M. Rudolph et al.
EXPERIMENTAL DERMATOLOGY (2014)
Phenotype profiling of primary testicular diffuse large B-cell lymphomas
Thomas Menter et al.
HEMATOLOGICAL ONCOLOGY (2014)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
Macrophages: Supportive cells for tissue repair and regeneration
Benedicte Chazaud
IMMUNOBIOLOGY (2014)
Targeting human dendritic cells in situ to improve vaccines
Kartik Sehgal et al.
IMMUNOLOGY LETTERS (2014)
Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8+ T cell response: A comparative study
Luis J. Cruz et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Nanoparticle-Mediated Combinatorial Targeting of Multiple Human Dendritic Cell (DC) Subsets Leads to Enhanced T Cell Activation via IL-15-Dependent DC Crosstalk
Kartik Sehgal et al.
JOURNAL OF IMMUNOLOGY (2014)
A Think Tank of TINK/TANKs: Tumor-Infiltrating/Tumor-Associated Natural Killer Cells in Tumor Progression and Angiogenesis
Antonino Bruno et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Imaging macrophages with nanoparticles
Ralph Weissleder et al.
NATURE MATERIALS (2014)
Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
Jacy Crosby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
Yizhou Dong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
RNAi-mediated silencing of hepatic Alas1 effectively prevents and treats the induced acute attacks in acute intermittent porphyria mice
Makiko Yasuda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Trial watch: Dendritic cell-based anticancer therapy
Norma Bloy et al.
ONCOIMMUNOLOGY (2014)
Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
Theerawut Chanmee et al.
CANCERS (2014)
Size effect of amphiphilic poly(γ-glutamic acid) nanoparticles on cellular uptake and maturation of dendritic cells in vivo
Fumiaki Shima et al.
ACTA BIOMATERIALIA (2013)
Dendritic cell-based nanovaccines for cancer immunotherapy
Leonie E. Paulis et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Targeted drug delivery to macrophages
Narendra K. Jain et al.
EXPERT OPINION ON DRUG DELIVERY (2013)
Dendritic-Cell-Based Therapeutic Cancer Vaccines
Karolina Palucka et al.
IMMUNITY (2013)
Inactivation of tumor-specific CD8+ CTLs by tumor-infiltrating tolerogenic dendritic cells
Hirotomo Harimoto et al.
IMMUNOLOGY AND CELL BIOLOGY (2013)
Immune system targeting by biodegradable nanoparticles for cancer vaccines
Joana M. Silva et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
Melanie Bruchard et al.
NATURE MEDICINE (2013)
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Stephanie M. Pyonteck et al.
NATURE MEDICINE (2013)
Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis
Teresa Coelho et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Applications of nanotechnology for immunology
Douglas M. Smith et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Deciphering the Message Broadcast by Tumor-Infiltrating Dendritic Cells
Nina Karthaus et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Nanobody-Based Targeting of the Macrophage Mannose Receptor for Effective In Vivo Imaging of Tumor-Associated Macrophages
Kiavash Movahedi et al.
CANCER RESEARCH (2012)
Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8+ T-cell responses in melanoma patients
Simone M. Goldinger et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Targeting tumor antigens to dendritic cells using particulate carriers
Medha D. Joshi et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Macrophage Migration Inhibitory Factor Promotes Tumor Growth and Metastasis by Inducing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Kendra D. Simpson et al.
JOURNAL OF IMMUNOLOGY (2012)
Myeloid-derived Suppressor Cells in Cancer Patients: A Clinical Perspective
Alberto J. Montero et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Targeting the Hemoglobin Scavenger receptor CD163 in Macrophages Highly Increases the Anti-inflammatory Potency of Dexamethasone
Jonas H. Graversen et al.
MOLECULAR THERAPY (2012)
Functionalized Polystyrene Nanoparticles Trigger Human Dendritic Cell Maturation Resulting in Enhanced CD4+T Cell Activation
Stefanie U. Frick et al.
MACROMOLECULAR BIOSCIENCE (2012)
Re(de)fining the dendritic cell lineage
Ansuman T. Satpathy et al.
NATURE IMMUNOLOGY (2012)
Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells
Tatiana I. Novobrantseva et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2012)
被撤回的出版物: FOXO3 A master switch for regulating tolerance and immunity in dendritic cells (Retracted article. See vol. 5, 2016)
Stephanie K. Watkins et al.
ONCOIMMUNOLOGY (2012)
Application of polysaccharides for surface modification of nanomedicines
Kyung-Oh Doh et al.
THERAPEUTIC DELIVERY (2012)
Cross-presentation by dendritic cells
Olivier P. Joffre et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Cancer immunotherapy via dendritic cells
Karolina Palucka et al.
NATURE REVIEWS CANCER (2012)
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Unique Gene-Silencing and Structural Properties of 2 '-Fluoro-Modified siRNAs
Muthiah Manoharan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells
Samantha Solito et al.
BLOOD (2011)
Selective gene delivery in dendritic cells with mannosylated and histidylated lipopolyplexes
Federico Perche et al.
JOURNAL OF DRUG TARGETING (2011)
Tumor-Infiltrating Programmed Death Receptor-1+ Dendritic Cells Mediate Immune Suppression in Ovarian Cancer
James Krempski et al.
JOURNAL OF IMMUNOLOGY (2011)
Mannose-Functionalized Pathogen-like Polyanhydride Nanoparticles Target C-Type Lectin Receptors on Dendritic Cells
Brenda Carrillo-Conde et al.
MOLECULAR PHARMACEUTICS (2011)
Biomedical nanoparticles modulate specific CD4+ T cell stimulation by inhibition of antigen processing in dendritic cells
Fabian Blank et al.
NANOTOXICOLOGY (2011)
Unexpected origins of the enhanced pairing affinity of 2′-fluoro-modified RNA
Pradeep S. Pallan et al.
NUCLEIC ACIDS RESEARCH (2011)
Targeting human dendritic cell subsets for improved vaccines
Hideki Ueno et al.
SEMINARS IN IMMUNOLOGY (2011)
Myeloid-Derived Suppressor Cells in Human Cancer
Srinivas Nagaraj et al.
CANCER JOURNAL (2010)
Immature Immunosuppressive CD14+HLA-DR-/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign
Isabel Poschke et al.
CANCER RESEARCH (2010)
5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
Julie Vincent et al.
CANCER RESEARCH (2010)
The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity
Je-In Youn et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway
Marta Coscia et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
Philip W. Kantoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8α+ dendritic cells
Karine Crozat et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells
Annabell Bachem et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Memory and Effector CD8 T-cell Responses After Nanoparticle Vaccination of Melanoma Patients
Daniel E. Speiser et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Novel RNA-based Strategies for Therapeutic Gene Silencing
Christopher R. Sibley et al.
MOLECULAR THERAPY (2010)
Targeted Delivery of siRNA to Macrophages for Anti-inflammatory Treatment
Sang-Soo Kim et al.
MOLECULAR THERAPY (2010)
Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
Akin Akinc et al.
MOLECULAR THERAPY (2010)
Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies
Rebecca Klippstein et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2010)
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Mark E. Davis et al.
NATURE (2010)
Lipid-like materials for low-dose, in vivo gene silencing
Kevin T. Love et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Immunomodulatory nanoparticles as adjuvants and allergen-delivery system to human dendritic cells: Implications for specific immunotherapy
Sissela Broos et al.
VACCINE (2010)
Lipid-based systemic delivery of siRNA
Yu-Cheng Tseng et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy
C. Marcela Diaz-Montero et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Suzanne Ostrand-Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2009)
siRNA Targeted to p53 Attenuates Ischemic and Cisplatin-Induced Acute Kidney Injury
Bruce A. Molitoris et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Transforming Growth Factor β: Tumor Suppressor or Promoter? Are Host Immune Cells the Answer?
Li Yang et al.
CANCER RESEARCH (2008)
Mannose-targeted systems for the delivery of therapeutics
Juan M. Irache et al.
EXPERT OPINION ON DRUG DELIVERY (2008)
Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment
Diego O. Croci et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Dendritic cell subsets in health and disease
Hideki Ueno et al.
IMMUNOLOGICAL REVIEWS (2007)
Dendritic-cell immunotherapy:: from ex vivo loading to in vivo targeting
Paul J. Tacken et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Phagocytosis and antigen presentation in dendritic cells
Ariel Savina et al.
IMMUNOLOGICAL REVIEWS (2007)
Taking dendritic cells into medicine
Ralph M. Steinman et al.
NATURE (2007)
A subset of dendritic cells induces CD4+ T cells to produce IFN-γ by an IL-12 independent but CD70-dependent mechanism in vivo
Helena Soares et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Targeting of antigen to dendritic cells with poly(γ-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity
Tomofumi Uto et al.
JOURNAL OF IMMUNOLOGY (2007)
Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: Formulation of a model vaccine for respiratory syncytial virus
Patricia L. Mottram et al.
MOLECULAR PHARMACEUTICS (2007)
Uptake characteristics of NGR-coupled stealth PEI/pDNA nanoparticles loaded with PLGA-PEG-PLGA tri-block copolymer for targeted delivery to human monocyte-derived dendritic cells
Stanley Moffatt et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Stable cationic microparticles for enhanced model antigen delivery to dendritic cells
Christian Wischke et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Position-specific chemical modification of siRNAs reduces off-target'' transcript silencing
Aimee L. Jackson et al.
RNA (2006)
Expression of human DEC-205 (CD205) multilectin receptor on leukocytes
Masato Kato et al.
INTERNATIONAL IMMUNOLOGY (2006)
Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host
B Huang et al.
CANCER RESEARCH (2006)
Cell biology of antigen processing in vitro and in vivo
ES Trombetta et al.
ANNUAL REVIEW OF IMMUNOLOGY (2005)
Size-dependent immunogenicity: Therapeutic and protective properties of nano-vaccines against tumors
T Fifis et al.
JOURNAL OF IMMUNOLOGY (2004)
Targeting dendritic cells with antigen-containing liposomes: A highly effective procedure for induction of antitumor immunity and for tumor immunotherapy
CL van Broekhoven et al.
CANCER RESEARCH (2004)
Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo
D Hawiger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?
L Thiele et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Dendritic cells: Specialized and regulated antigen processing machines
I Mellman et al.
CELL (2001)
Development of mouse dendritic cells from lineage-negative c-kit(low)pluripotent hemopoietic stem cells in vitro
B Feng et al.
STEM CELLS (2000)
Share Paper
